Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fionnuala King"'
Autor:
Cathal Walsh, Michael Harrison, Richard W Costello, Roisin Adams, Desmond M Murphy, Caroline O'Leary, Christopher Schultz, Deborah Casey, Stephen Lane, Shane Doyle, Fionnuala King
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Introduction Interleukin 5 (IL-5) inhibitors are an important therapeutic advance in the management of severe, refractory, eosinophilic asthma. However, their utilisation should be targeted to maximise their benefits. This study used multisite, centr
Externí odkaz:
https://doaj.org/article/f95968b6c0f14940885f3c67b2e591a1
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e112479 (2014)
Reducing health care costs requires the ability to identify patients most likely to incur high costs. Our objective was to evaluate the ability of the Charlson comorbidity score to predict the individuals who would incur high costs in the subsequent
Externí odkaz:
https://doaj.org/article/7c61ca0e42c94058951c66e9cb17b18e
Autor:
Caroline, O'Leary, Christopher, Schultz, Cathal, Walsh, Roisin, Adams, Deborah, Casey, Stephen, Lane, Michael, Harrison, Shane, Doyle, Richard W, Costello, Fionnuala, King, Desmond M, Murphy
Publikováno v:
BMJ Open Respiratory Research. 9:e001341
IntroductionInterleukin 5 (IL-5) inhibitors are an important therapeutic advance in the management of severe, refractory, eosinophilic asthma. However, their utilisation should be targeted to maximise their benefits. This study used multisite, centra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f538edcb15f7b739529b7c2775ecda1
https://doi.org/10.1136/bmjresp-2022-001341
https://doi.org/10.1136/bmjresp-2022-001341
Autor:
Ralph Ullman, Fionnuala King, Patricia Zybert, Corey H. Basch, Alfred I. Neugut, Steven Shea, Randi L. Wolf, Celia Shmukler, Charles E. Basch
Publikováno v:
Journal of Community Health. 40:975-983
This randomized controlled trial assessed different educational approaches for increasing colorectal cancer screening uptake in a sample of primarily non-US born urban minority individuals, over aged 50, with health insurance, and out of compliance w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e81fb97ba0449d0903e9adb7cf124117
https://doi.org/10.1007/s10900-015-0021-5
https://doi.org/10.1007/s10900-015-0021-5
Introduction of a dose-banding system for parenteral chemotherapy on a haematology-oncology day ward
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(2)
Introduction The increasing incidence of cancer and the finite capacity of hospital aseptic compounding units pose a serious challenge to the provision of cancer care. Chemotherapy dose-banding is a method of rationalising parenteral chemotherapy dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1271268389cc8a1e6503c9ebd1fda478
https://pubmed.ncbi.nlm.nih.gov/29059028
https://pubmed.ncbi.nlm.nih.gov/29059028
Autor:
Corey H. Basch, Celia Shmukler, Fionnuala King, Ralph Ullman, Randi L. Wolf, Alfred I. Neugut, Charles E. Basch, Patricia Zybert
Publikováno v:
Journal of community health. 41(3)
The study examines the role of patient colorectal cancer (CRC) screening test preference and CRC screening uptake in an insured, urban minority population. Study subjects were enrolled in a randomized controlled trial to promote CRC screening. The in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::943e84740da4721dc25aa32c49a40009
https://pubmed.ncbi.nlm.nih.gov/26585609
https://pubmed.ncbi.nlm.nih.gov/26585609
Publikováno v:
International journal of clinical pharmacy. 34(6)
Background Oral anticancer medicines (OAM) facilitate transfer of cancer care into the community, where safeguards developed in hospitals that control their prescribing, dispensing and administration may not exist. Objective To determine if the syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bd67396378332d5b9d6b54f3f039c0
https://pubmed.ncbi.nlm.nih.gov/22961608
https://pubmed.ncbi.nlm.nih.gov/22961608
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 15(4)
Background. Pregnancy-associated (PA) breast cancer is a rare disease state that poses unique management challenges, specifically controlling the cancer and maximizing the survival of the expectant mother balanced with the health and safety of the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc0f49a946da5472acfefd657eca147
https://pubmed.ncbi.nlm.nih.gov/19304882
https://pubmed.ncbi.nlm.nih.gov/19304882
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e112479 (2014)
PLoS ONE
PLoS ONE
Background Reducing health care costs requires the ability to identify patients most likely to incur high costs. Our objective was to evaluate the ability of the Charlson comorbidity score to predict the individuals who would incur high costs in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc38b5d50bbce4c5cc7d1a8505fad90
https://doi.org/10.1371/journal.pone.0112479
https://doi.org/10.1371/journal.pone.0112479